AHG AHG
Company Profile ↓Company Overview
AHG (AHG) is a publicly traded company listed on with a market capitalization of $3.75B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.21.
Recent Developments
- Mar 2026 Revenue of $13.83M (-6.4% YoY); net profit $-18.67M.
- Trailing 12 Months Year-on-year growth — revenue -6.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.6%, profit CAGR -424.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.62% |
| 1 Year: | -6.40% |
Compounded Profit Growth
| 5 Years: | -424.33% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -10.98% |
| 6 Months: | +0.00% |
| 3 Months: | -33.64% |
| 1 Month: | -6.41% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)48.17 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Earnings shrank at -424.3% CAGR over 5 years.
- Trading 41.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 13.18M | 2.41M | 14.78M | 13.83M |
| Cost of Revenue | - | 11.91M | 2.29M | 15.06M | 13.84M |
| Gross Profit | - | 1.27M | 122.13K | -281.53K | -11.31K |
| Operating Expenses | - | 15.54M | 8.76M | 3.64M | 3.99M |
| Operating Income | - | -14.27M | -8.64M | -3.92M | -4.00M |
| EBITDA | - | -14.27M | -8.64M | -1.77M | -1.63M |
| Interest Expense | 804.14K | 0 | 0 | - | - |
| Pretax Income | - | -13.07M | -9.09M | -166.27M | -20.70M |
| Tax Provision | - | 17.55K | 24.99K | -30.80M | -1.99M |
| Net Income | - | -1.36M | -9.46M | -134.98M | -18.67M |
| Diluted EPS | - | -0.06 | -0.21 | -0.48 | -0.03 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 20.46M | 142.02M | 214.95M | 189.63M |
| Current Assets | - | 20.46M | 142.02M | 196.12M | 189.55M |
| Cash & Equivalents | - | 7.92M | 85.17M | 176.23M | 170.57K |
| Inventory | - | 1.69M | 191.20K | 190.24K | 200.13K |
| Receivables | - | 7.70M | 0 | 954.20K | 1.28M |
| Total Liabilities | - | 11.62M | 3.59M | 15.80M | 8.71M |
| Current Liabilities | - | 11.62M | 3.59M | 13.81M | 8.71M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | - | 0 | 81.74K | 375.66K |
| Total Equity | - | 8.73M | 138.37M | 199.12M | 180.93M |
| Shares Outstanding | - | 69.76M | 438.34M | 1.65B | 2.57B |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -3.25M | 1.35M | 1.18M | -12.79M |
| Investing Cash Flow | - | 18.47M | -54.72M | -105.91M | -163.46M |
| Financing Cash Flow | - | -27.51M | 131.65M | 195.88M | 350.00K |
| Capital Expenditure | -4.86K | - | - | -154.46K | -175.67M |
| Free Cash Flow | - | -3.25M | 1.35M | 1.02M | -188.46M |
| Net Change in Cash | - | -12.30M | 78.28M | 91.15M | -175.91M |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 9.6% | 5.1% | -1.9% | -0.1% |
| Operating Margin % | - | -108.2% | -357.8% | -26.5% | -28.9% |
| Net Margin % | - | -10.3% | -391.8% | -913.4% | -135.0% |
| ROE % | - | -15.6% | -6.8% | -67.8% | -10.3% |
| ROCE % | - | -161.4% | -6.2% | -2.0% | -2.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AHG
Akso Health Group (AHG) Stock Looks Expensive Despite Stronger Quarterly Revenue - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxNXzYyMkY1R0h1bzhQRUhHRGtFWm53ME9zZHBtUmozbmNQRW42bXpyaE5Zc1hQSXJvNWxxQzdwTjVqZ2lUc3V0X2xBeFVBNnpRSkkyb1J3QmhHaTZqY3RyOU5LMXJjYXFTbi05enl3WHVwN25rLVFudl9VbWhoQ2lTTkNyVDZoaDVlUGZvcH…
AHG|Akso Health Group|Price:1.350|Chg%:-0.220 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE8tUHE1anJWNlBzQmhYa25Dam5jS01BQXlvUkRtQUVjQ2EtYlJUX2d0dm5ScnBUQjNCNk5LRnVWdlVIeGdSZm9oM0VMRTU5Y2ZmX3lZaTdQNkRNd1psLXJ0XzBSQ2FDMXE2VVM2cA?oc=5" target="_blank">AHG|Akso Health Group…
Akso Health Group Revenue Breakdown – NASDAQ:AHG - TradingView
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBheWZDd2RsX1l0U1RDYnpla0xlcE8ySjVqYVBQS1AyaHItSGRJVlBuX0ZoWUJ6ck5oeVFTcmtyVG9HdklLVDdabzdRMER6MXJYaW9MR2xEdzVxN1JDZVJaR0J4UkhIelVsbnNTUWZwdlB0QkFBLWc?oc=5" target="_blank">Akso Hea…
The Bull Case For Akso Health Group (AHG) Could Change Following Sharply Narrowed Full-Year Net Loss - Learn Why - Sahm
<a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxOM25BWENfUnp2S3JmZWFvbXZISXNUajY1RU0wRGdTa3hvMGZYWkd5dnFIMHNBVmI0dzB0X0FPM3J5WTdwU01zOExEMm82R0QyMm5iblFIckFIR2s2NVR3MS1WNTZMWTNocko5dFA2dkMtRTdBMmZWeU5pWjI4dDh2a29Qa24tdktDb0U5OU…
Akso Health Group (AHG) Dips to $1.57, Holding Above Key Support - Gap Fill Strategy - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQdGZEbE5mV2JMbzFzYmRldUpoRW0wVU51Q2RrU01DMmlrYmZPYnp0eGJYNm9vaC13WUdRNHVmcVNuNWZRLXpZRm5hMlYtTmNYcFNXQl92dHY4UVRqeWlGNUdGemhrS0VpVlp2YTZ3VG5QTGtSUng3bDBlVHdOM0ktZWZRdUNlWEk5b2lCNW…
Akso Health Group (AHG) Dips 6.75%: Testing Key Support Near $1.44 - Take Profit Levels - po-news-eg.net
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNUVhKWks2OVk0eko0RlpyTHpNRnl5SURwOWxuWDk4cml4aThsejBQcVdtWXpaUFdycHhFYTZ6ZkxnUUdBLTBBbWozUE1FeGp3bjNuMHIyY0Znc2p5Rm5KSnQtbm1hTjA3algxbVZBSFZEbjFjd2RpVnRNdDc3MVdkSElpYXpkVmpMdW5SbF…
AHG — Frequently Asked Questions
What is the current share price of AHG?
As of 2026-08-05 17:25 PDT, AHG trades at $1.46 on NASDAQ/NYSE. Its 52-week range is $1.16 to $2.50.
What is the market capitalisation of AHG?
AHG has a market capitalisation of $3.75B on NASDAQ/NYSE.
What is the P/E ratio of AHG?
AHG trades at a trailing price-to-earnings (P/E) ratio of -48.67. Its price-to-book (P/B) ratio is 20.74.
What is the return on equity (ROE) of AHG?
AHG has a return on equity (ROE) of -10.32%. Its return on capital employed (ROCE) is -2.21%.
Is AHG a good stock to buy?
This page provides a data-driven analysis of AHG, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.